Trivarx (ASX:TRI) - Key People
ASX:TRI · Directors, executives and key personnel · 12 month lookback
Dr Tony Keating
Current
Executive Director
Mentioned in
Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026
2 May 2026
TrivarX Advances Stabl-Im Brain Imaging Toward Phase 1 Trials with New CEO Appointment
30 Apr 2026
Healthcare Wrap - Week 9 (23 Feb -> 27 Feb) 2026
28 Feb 2026
TrivarX Advances Neuro-Oncology with $4.2M Raise and Stabl-Im Acquisition
24 Feb 2026
Dr Danielle Meyrick
Current
Chief Executive Officer
Mentioned in
Healthcare Wrap - Week 21 (18 May -> 22 May) 2026
23 May 2026
TrivarX Engages CRO Beyond to Advance Stabl-Im Phase 1 Trial
22 May 2026
Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026
2 May 2026
TrivarX Advances Stabl-Im Brain Imaging Toward Phase 1 Trials with New CEO Appointment
30 Apr 2026
Dr Thomas R. Young
Current
Chief Executive Officer
No articles mention this person in the last 12 months.
David Trimboli
Current
Non‑Executive Chairman
Mentioned in
Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026
2 May 2026
TrivarX Advances Stabl-Im Brain Imaging Toward Phase 1 Trials with New CEO Appointment
30 Apr 2026
TrivarX Names Dr Danielle Meyrick CEO to Lead Stabl-Im Brain Cancer Imaging Trials
29 Apr 2026
Healthcare Wrap - Week 9 (23 Feb -> 27 Feb) 2026
28 Feb 2026
Also Mentioned
People named in Trivarx (ASX:TRI) articles over the last 12 months, by frequency.
Henry Jordan
· 13 articles
Daniel Tillett
· 9 articles
John Mathias
· 4 articles
Kai Sun
· 3 articles
Jennifer Martin
· 3 articles
Chris Ntoumenopoulos
· 2 articles
Archie Defillo
· 2 articles
Christopher Ntoumenopoulos
· 2 articles
Stephen Buckley
· 2 articles
Tania Marti-Warren
· 2 articles
Chris Ntoumenopolous
· 1 article
Junior Noboa
· 1 article